| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Email Marketing > Boost Email Open Rates and Clickthrough Rates with Transactional Emails in Online Marketing |
|
Main Subject - Boost Email Open Rates and Clickthrough Rates with Transactional Emails in Online Marketing
One of your toughest challenges in email marketing is
persuading people to open and read your email sales
pitc According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product h. Your customers are busy, and distracted, and
inundated with spam. No wonder the average open
rate is a mere ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in 35.5 percent, according to email service
provider Harte-Hanks Postfuture. The secret to improving your email op lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. en rates is to
make your messages more timely and more relevant.
And there’s no better place to do both than i here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
transactional email. Transactional email messages
are the ones you send to website visitors who have
transa d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro cted business on your website. An email that
confirms a purchase is a transactional email. An
email notifying ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc customer that a product has just
shipped is a transactional email. Research by Harte-Hanks Postfuture demonstr easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ates
that customers open transactional email messages
more than 70 percent of the time. That’s double the
o nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically en rate for traditional opt-in email messages.
Clickthrough rates are also higher, reaching more
than 50 perce and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ nt when the transactional email includes
a link to a discount offer. Traditional opt-in emails
generate only 6 ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi 6 percent clickthroughs according to
email marketer ExactTarget. Open rates and clickthrough rates are higher i ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a
transactional email because transactional emails
reach people who have just bought from you or asked
you fo dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod r more information. So they are expecting to hear
from you. What all of this means for your business is that a cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin promotion or offer included in a transactional email is
about twice as likely to be read as the same message
tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen sent in a traditional email. Some tips: 1. Personalize. Speak to your new customer by name. Name what s t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e just bought, or name what
she just signed up to receive. Be specific to show that
your message is timely and ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust relevant. 2. Thank before you pitch. Make your transactional email look transactional. If it’s a receip y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ,
make it look like a receipt. If it’s a welcome message,
make sure it says welcome. Put your offer or
promo . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de tion after the thank-you or welcome. 3. Offer something of value. Don’t just try to sell your new custom elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip r something else. Offer an
incentive, such as savings on future purchases or an
exclusive discount on supplies tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Advantages of Buying An Existing Business Business Partnerships - Doing It Right
|